Misoprostol for Small Bowel Ulcers and Obscure Bleeding Due to Aspirin or Nonsteroidal Antiinflammatory Drugs
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.
Also called NCT02202967
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 104 participants
- Registry
-
NCT02202967 -
2013-003187-31
-
- Main results
- Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02202967. Randomized; quadruple masking; primary purpose treatment. Start 2016-01-07 (actual); primary completion 2017-10-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Misoprostol for Small Bowel Ulcers and Obscure Bleeding Due to Aspirin or Nonsteroidal Antiinflammatory Drugs
- Acronym
- MASTERS
- Condition
- Chronic Arthritis
- Condition
- Ischemic Heart Disease
- Condition
- Atrial Fibrillation
- Condition
- Anemia
- Condition
- Bleeding
- Intervention (Drug)
- Misoprostol
- Intervention (Drug)
- Placebo
- Lead sponsor
- NHS Greater Glasgow and Clyde
Record details
- Record id
cardio:ct-nct02202967- Content hash
3bebf64ff7d595701c55290947ba6dd11e0a205d9d4897d8000730d6cef58c95